Kirkland-based heart care company Cardiac Dimensions on Thursday raised a $53 million Series E round.

The U.S. Food and Drug Administration (FDA) has approved a new drug for a serious heart condition that affects thousands of ...

Cardiac Dimensions, a Kirkland, Wash., company with a technology to treat heart valve malfunction, has raised $53 million ...

Researchers have developed a smartphone app that uses machine learning to accurately determine body composition—which is ...

Studies conducted in human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) compared various cassette configurations and informed the final design of TN-201, which incorporates a ...

In a new case study, researchers from North Carolina State University found Bartonella henselae, Babesia odocoilei and Babesia divergens-like MO-1 DNA in brain tissue samples from a young child with ...

The alpha-gal syndrome is thought to be triggered by bites from the lone star tick. Emerging evidence suggests other ticks—found in other parts of the country—may also cause it. Most cases, scientists ...

Ajai Chari, MD, University of California San Francisco, explores the challenges that accompany integrating chimeric antigen receptor (CAR) T-cell therapies into multiple myeloma treatment.

Critics say a new, broader definition of high-risk plaque opens the door to more tests, diagnoses, and invasive procedures, steering us down a potentially harmful path.

VAEs also introduce mathematical constraints that accommodate computational models called large neural networks. To continue with the example of large language models, these neural networks can be ...

By combining ultrasound, photoacoustics, and imaging, Richard Lopata brings medical technologies from concept to clinical ...

The rapid development of gene therapy options for treating neuromuscular diseases has created new therapeutic options but ...